Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000069.xml
Download PDF
Semin Liver Dis 2000; Volume 20(Number 03): 373-384
DOI: 10.1055/s-2000-9390
DOI: 10.1055/s-2000-9390
Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders
Further Information
Publication History
Publication Date:
31 December 2000 (online)
ABSTRACT
Recent advances in the molecular cloning of membrane transport systems that determine bile formation have facilitated studies of the molecular mechanisms of cholestatic liver disease. The present review summarizes what has been learned about the molecular alterations of these membrane transporters in hepatocytes and cholangiocytes in acquired cholestatic liver disorders. Much of this information has been obtained from the study of animal models of cholestasis and from more limited studies in clinical cholestatic liver diseases. Many of these responses may be interpreted as adaptations that serve to diminish cholestatic liver injury.
KEYWORD
cholestasis - membrane transporters - hepatocyte - cholangiocyte - export pumps
REFERENCES
- 1 Trauner M, Meier P J, Boyer J L. Molecular pathogenesis of cholestasis. N Engl J Med . 1998; 339 1217-1227
- 2 Bezerra J A, Balistreri W F. Intrahepatic cholestasis: Order out of chaos. Gastroenterology . 1999; 117 1496-1498
- 3 Kartenbeck J, Leuschner U, Mayer R. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology . 1996; 23 1061-1066
- 4 Paulusma C C, Kool M, Bosma P J. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology . 1997; 25 1539-1542
- 5 Wada M, Toh S, Taniguchi K. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet . 1998; 7 203-207
- 6 Bull L N, van Eijk M JT, Pawlikowska L. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet . 1998; 18 219-224
- 7 Strautnieks S S, Kagalwalla A F, Tanner M S. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet . 1997; 61 630-633
- 8 Deleuze J F, Jacquemin E, Dubuisson C. Defect on multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology . 1996; 23 904-908
- 9 deVree J ML, Jacquemin E, Sturm E. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA . 1998; 95 282-287
- 10 Jansen P L, Strautnieks S S, Jacquemin E. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology . 1999; 117 1370-1379
- 11 Balistreri W F, Schubert W K. Liver diseases in infancy and childhood. In: Schiff L, Schiff ER, eds
Diseases of the liver, 6th ed. Philadelphia: J.B. Lippincott, 1987: 1337-1427
MissingFormLabel
- 12 Trauner M, Meier P J, Boyer J L. Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol . 1999; 31 165-178
- 13 Müller M, Jansen P LM. Molecular aspects of hepatobiliary transport. Am J Physiol . 1997; 35 G1285-G1303
- 14 Boyer J L, Nathanson M H. Bile formation. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver, 8th ed
New York: Lippincott-Raven, 1999: 119-146
MissingFormLabel
- 15 Fitz J G, Scharschmidt B F. Regulation of transmembrane electrical potential gradient in rat hepatocytes in situ. Am J Physiol . 1987; 252 G56-G64
- 16 Graf J, Henderson R M, Krumpholz B. Cell membrane and transepithelial voltages and resistances in isolated rat hepatocyte couplets. J Membr Biol . 1987; 95 241-254
- 17 Hagenbuch B, Meier P J. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Sem Liver Dis . 1996; 16 129-136
- 18 Hagenbuch B, Stieger B, Foguet M. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci USA . 1991; 88 10629-10633
- 19 Hagenbuch B, Meier P J. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest . 1994; 93 1326-1331
- 20 Jacquemin E, Hagenbuch B, Stieger B. Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA . 1994; 91 133-137
- 21 Kullak-Ublick G A, Hagenbuch B, Stieger B. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology . 1995; 109 1274-1282
- 22 Abe T, Kakyo M, Sakagami H. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem . 1998; 273 22395-22401
- 23 Reichel C, Gao B, Van Montfoort J. Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver. Gastroenterology . 1999; 117 688-695
- 24 Noe B, Hagenbuch B, Stieger B. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA . 1997; 94 10346-10350
- 25 Abe T, Kakyo M, Tokui T. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem . 1999; 274 17159-17163
- 26 Kakyo M, Unno M, Tokui T. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology . 1999; 117 770-775
- 27 Konig J, Cui Y, Nies A T. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol . 2000; 278 G156-G164
- 28 Hsiang B, Zhu Y, Wang Z. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl- CoA reductase inhibitor transporters. J Biol Chem . 1999; 274 37161-37168
- 29 Konig J, Nies A T, Cui Y. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta . 1999; 1461 377-394
- 30 Hirohashi T, Suzuki H, Ito K. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol . 1998; 53 1068-1075
- 31 Hirohashi T, Suzuki H, Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem . 1999; 274 15181-15185
- 32 Ogawa K, Suzuki H, Hirohashi T. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol . 2000; 278 G438-G446
- 33 Smit J JM, Schinkel A H, Elferink R PJO. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell . 1993; 75 451-462
- 34 Ruetz S, Gros P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell . 1994; 77 1071-1081
- 35 Oude Elferink R PJ, Tytgat G NJ, Groen A K. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J . 1997; 11 19-28
- 36 Paulusma C C, Bosma P J, Zaman G JR. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science . 1996; 271 1126-1128
- 37 Buechler M, Koenig J, Brom M. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem . 1996; 271 15091-15098
- 38 Keppler D, Konig J. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J . 1997; 11 509-516
- 39 Paulusma C, van Geer M, Evers R. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J . 1999; 338 393-401
- 40 Ballatori N, Truong A T. Relation between biliary glutathione excretion and bile acid-independent bile flow. Am J Physiol . 1989; 256 G22-G30
- 41 Gerloff T, Stieger B, Hagenbuch B. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem . 1998; 273 10046-10050
- 42 Strautnieks S S, Bull L, Knisely A S. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet . 1998; 20 233-238
- 43 Sippel C J, McCollum M J, Perlmutter D H. Bile acid transport by the rat liver canalicular bile acid transport/ecto-ATPase protein is dependent on ATP but not on its own ecto-ATPase activity. J Biol Chem . 1994; 269 2820-2826
- 44 Thiebaut F, Tsuruo T, Hamada H. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Nat Acad Sci USA . 1987; 84 7735-7738
- 45 Kamimoto Y, Gatmaitan Z, Hsu J. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem . 1989; 264 11693-11698
- 46 Kool M, de Haas G L, Scheffer G L. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res . 1997; 57 3537-3547
- 47 Kool M, van der Linden M, de Haas M. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res . 1999; 59 175-182
- 48 Borst P, Evers R, Kool M. The multidrug resistance protein family. Biochim Biophys Acta . 1999; 1461 347-357
- 49 Ujhazy P, Ortiz D F, Misra S. ATP-dependent aminophospholipid translocase activity in rat canalicular membrane vesicles and its relationship to FIC1 [Abstract]. Hepatology . 1999; 30 462A
- 50 Boyer J L, Soroka C J. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology . 1995; 109 1600-1611
- 51 Roelofsen H, Soroka C, Dietrich K. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci . 1998; 111 1137-1145
- 52 Che M, Gatmaitan Z, Arias I M. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. FASEB J . 1997; 11 101-108
- 53 Martinez-Anso E, Castillo J E, Diez J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology . 1994; 19 1400-1406
- 54 Cohn J A, Strong T V, Picciotto M R. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology . 1993; 105 1857-1864
- 55 Strazzabosco M, Joplin R, Zsembery A. Na+-dependent and -independent C1-/HCO- 3 exchange mediate cellular HCO- 3 transport in cultured human intrahepatic bile duct cells. Hepatology . 1997; 25 976-985
- 56 Strazzabosco M, Boyer J L. Ion transporters that regulate intracellular pH and secretion in bile duct epthelial
cells. In: Sirica AE, Longnecker DS, eds
Biliary and pancreatic ductal epithelia: Pathobiology and pathophysiology. New York:
Marcel Dekker, 1997: 85-106
MissingFormLabel
- 57 Welsh M J, Smith A E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell . 1993; 73 1251-1254
- 58 Colombo C, Battezzati P M, Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis . 1994; 14 259-269
- 59 Colombo C, Crosignani A, Battezzati P M. Liver involvement in cystic fibrosis. J Hepatol . 1999; 31 946-954
- 60 Moseley R H, Wang W, Takeda H. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis. Am J Physiol . 1996; 271 G137-G146
- 61 Moseley R H. Sepsis-associated cholestasis. Gastroenterology . 1997; 112 302-306
- 62 Green R M, Beier D, Gollan J L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology . 1996; 111 193-198
- 63 Whiting J F, Green R M, Rosenbluth A B. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology . 1995; 22 1273-1278
- 64 Bolder U, Huong-Thu T, Schteingart C D. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion. Gastroenterology . 1997; 112 214-225
- 65 Trauner M, Arrese M, Soroka C. The rat canalicular conjugate export pump (mrp 2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology . 1997; 113 255-264
- 66 Trauner M, Arrese M, Lee H. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest . 1998; 101 2092-2100
- 67 Vos T A, Guido J, Hooiveld E J. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology . 1998; 28 1637-1644
- 68 Lee J M, Trauner M, Soroka C J. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology . 2000; 118 163-172
- 69 Simon F R, Fortune J, Iwahashi M. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol . 1996; 34 G1043-G1052
- 70 Gartung C, Ananthanarayanan M, Rahman M A. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology . 1996; 110 199-209
- 71 Latham P S, Menkes E, Phillips M J. Hyperalimentation-associated jaundice: An example of a serum factor inducing cholestasis in rats. Am J Clin Nutr . 1985; 41 61-65
- 72 Bossard R, Stieger B, O'Neill B. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest . 1993; 91 2714-2720
- 73 Roelofsen H, VanDerVeere C N, Ottenhoff R. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology . 1994; 107 1075-1084
- 74 Roelofsen H, Schoemaker B, Bakker C. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol . 1995; 32 G427-G434
- 75 Karpen S J, Sun A, Kudish B. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem . 1996; 271 15211-15221
- 76 Denson L A, Auld K L, Schiek D S. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem . 2000; 275 8835-8843
- 77 Makishima M, Okamoto A Y, Repa J J. Identification of a nuclear receptor for bile acids. Science . 1999; 284 1362-1365
- 78 Parks D J, Blanchard S G, Bledsoe R K. Bile acids: Natural ligands for an orphan nuclear receptor. Science . 1999; 284 1365-1368
- 79 Gartung C, Trauner M, Schlosser S F. Sodium-independent uptake of bile acids is unaffected by down-regulation of an organic anion transporter (oatp) in rat liver during cholestasis produced by common bile duct ligation (CBDL) [Abstract]. Hepatology . 1996; 24 369A
- 80 Kubitz R, Wettstein M, Warskulat U. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology . 1999; 116 401-410
- 81 Rost D, Kartenbeck J, Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin- induced cholestasis. Hepatology . 1999; 29 814-821
- 82 Green R M, Hoda F, Ward K L. Molecular cloning and characterization of the murine bile salt export pump. Gene . 2000; 241 117-123
- 83 Reyes H, Simon F R. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Semin Liver Dis . 1993; 13 289-301
- 84 Takikawa H, Takamori Y, Sano N. Changes in biliary excretory mechanisms in rats with ethinyl estradiol-induced cholestasis. J Gastroenterol Hepatol . 1998; 13 186-191
- 85 Stieger B, Fattinger K, Madon J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology . 2000; 118 422-430
- 86 Dumont M, Jacquemin E, D'Hont C. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol . 1997; 27 1051-1056
- 87 Hirohashi T, Suzuki H, Takikawa H. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem . 2000; 275 2905-2910
- 88 Paulusma C, Kothe M JC, Bakker C TM. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology . 2000; 31 684-693
- 89 Buscher H-P, Miltenberger C, Macnelly S. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. J Hepatol . 1989; 8 181-191
- 90 Michalopoulos G K, DeFrances M C. Liver regeneration. Science . 1997; 276 60-66
- 91 Higgins G H, Anderson R M. Experimental pathology of liver. 1. Restoration of liver of white rat following partial surgical removal. Arch Pathol . 1931; 12 186-202
- 92 Fukano S, Saitoh Y, Uchida K. Bile acid metabolism in partially hepatectomized rats. Steroids . 1985; 45 209-227
- 93 Xu H S, Rosenlof L K, Jones R S. Bile secretion and liver regeneration in partially hepatectomized rats. Ann Surg . 1993; 218 176-186
- 94 Sainz G R, Monte M J, Barbero E R. Bile secretion by the rat liver during synchronized regeneration. Int J Exp Pathol . 1997; 78 109-116
- 95 Klaassen C D. Comparison of the effects of two-thirds hepatectomy and bile duct ligation on hepatic excretory function. J Pharmacol Exp Ther . 1974; 191 25-31
- 96 Uesugi T, Bognacki J, Levine W G. Biliary excretion of drugs in the rat during liver regeneration. Biochem Pharmacol . 1976; 25 1187-1193
- 97 Green R M, Gollan J L, Hagenbuch B. Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol . 1997; 36 G621-G627
- 98 Gerloff T, Geier A, Stieger B. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology . 1999; 117 1408-1415
- 99 Vos T A, Ros J E, Havinga R. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology . 1999; 29 1833-1839
- 100 Nakatsukasa H, Silverman J A, Gant T W. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology . 1993; 18 1202-1207
- 101 Shneider B L, Fox V L, Schwarz K B. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology . 1997; 25 1176-1183
- 102 Kullak-Ublick G-A, Beuers U, Fahney C. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology . 1997; 26 991-997
- 103 Konig J, Rost D, Cui Y. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology . 1999; 29 1156-1163
- 104 Oswald M, Kullak-Ublick G-A, Beuers U. Expression of the hepatocyte canalicular multidrug resistance associated protein 2 (MRP2) in primary biliary cirrhosis [Abstract]. Hepatology . 1998; 28 544A
- 105 Nozawa S, Miyazaki M, Tou H I. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice [Abstract]. Gastroenterology . 1997; 112 A1349
- 106 Dumoulin F L, Reichel C, Sauerbruch T. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol . 1997; 26 852-856
- 107 Kogan D, Ananthanarayanan M, Emre S. The bile salt excretory pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA) [Abstract]. Hepatology . 1999; 30 468A
- 108 Trauner M, Zenz R, Fickert P. Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis [Abstract]. Hepatology . 1999; 30 467A
- 109 Desmet V J. Vanishing bile duct disorder. In: Boyer JL, Ockner RK, eds
Progress in liver diseases. Philadelphia: W.B. Saunders, 1992: 89-122
MissingFormLabel
- 110 Boyer J L. Vanishing bile duct syndrome-from bench to bedside. In: Alvaro D, Benedetti A, Strazzabosco M, eds. Vanishing bile duct syndrome-pathophysiology
and treatment
Lancaster: Kluwer Academic Publishers, 1997: 240-245
MissingFormLabel
- 111 Alvaro D, Gigliozzi A, Piat C. Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the C12-<>/HCO32-<> exchanger in the rat. J Hepatol . 1997; 26 146-157
- 112 Lazaridis K N, Pham L, Tietz P. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest . 1997; 100 2714-2721
- 113 Alpini G, Glaser S S, Rodgers R. Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology . 1997; 113 1734-1740
- 114 Lee J M, Azzaroli F, Gigliozzi A. Adaptive regulation of the ileal sodium-dependent bile salt transporter (ISBT), and the multispecific organic anion transporter (MRP2), in kidney and cholangiocytes in chronic cholestasis - alternative pathways for bile salt excretion [Abstract]. Hepatology . 1999; 30 417A
- 115 Benedetti A, DiSario A, Marucci L. Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. Am J Physiol . 1997; 35 G1416-G1424
- 116 Prieto J, Qian C, Garcia N. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology . 1993; 105 572-578
- 117 Medina J F, Martinez-Anso E, Vazquez J J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology . 1997; 25 12-17
- 118 Cohn J A, Friedman K J, Noone P G. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med . 1998; 339 653-658
- 119 Sharer N, Schwarz M, Malone G. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med . 1998; 339 645-652
- 120 Choudari C P, Lehman G A, Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin North Am . 1999; 28 543-549
- 121 Kool M, van der Linden M, de Haas M. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA . 1999; 96 6914-6919
- 122 Clayton R J, Iber F L, Ruebner B H. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child . 1969; 117 112-124
- 123 Jacquemin E, Cresteil D, Manouvrier S. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet . 1999; 353 210-211
- 124 Schrenk D, Gant T W, Preisegger K H. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology . 1993; 17 854-860